JENNIFER BELL: Open Payments
NPI 1669247243 · LINTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 51 payments from 16 companies in 2025. Trend: 2023 $32 · 2024 $542 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $201 |
| Vanda Pharmaceuticals Inc. | 5 | $129 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $127 |
| Novo Nordisk Inc | 5 | $85 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Aimmune Therapeutics, Inc. | 2 | $47 |
| ABIOMED | 1 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
Products named: VRAYLAR, FANAPT, CAPLYTA, Auvelity, QULIPTA, Jornay PM, AIRSUPRA, ZENPEP.
Industry payments across IN — which companies pay providers there.
